NIH-funded research Fellowship grant

Understanding how certain proteins cause cell death and inflammation

Official title: Revealing the Mechanisms of Cleaved and Intact GSDMD Pore Formation and Membrane Rupture

Funded at Harvard Medical School · NIH-11161933 · Data updated 2026-11-12

This study is looking at how a protein called gasdermin D helps cells die and release signals that cause inflammation, which could help us understand and improve treatments for diseases like Alzheimer's and other inflammatory conditions.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startMarch 1, 2025
Project endFebruary 29, 2028
Funding year2025
Award (this year)$43,456
NIH project number1F31AI191410-01
Project IDNIH-11161933 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with inflammatory diseases or neurodegenerative conditions such as Alzheimer's disease.

Less likely to help

Patients with non-inflammatory conditions or those not affected by neurodegenerative diseases may not benefit from this research.

What this research studies

This research investigates the mechanisms by which a specific protein, gasdermin D (GSDMD), forms pores in cell membranes, leading to cell death and the release of inflammatory signals. The study focuses on how the innate immune system detects harmful stimuli and activates a complex of proteins that can trigger inflammation. By examining the interactions between these proteins, researchers aim to uncover how dysregulation can lead to various diseases, including Alzheimer's and other inflammatory conditions. Patients may benefit from insights gained into how to better manage or treat these diseases.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating inflammatory diseases and conditions like Alzheimer's.

How similar studies have gone: Previous research has shown promising results in understanding the role of inflammasomes in various diseases, indicating that this approach has potential for significant findings.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Healy, Liam Brendan — Harvard Medical School
  • Study coordinator: Healy, Liam Brendan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.